10 research outputs found

    Have Lesser Scaup, Aythya affinis, Reproductive Rates Declined in Parkland Manitoba?

    Get PDF
    Long-term surveys indicate that the scaup populations have declined over the past 20 years, and that this is probably the result of decreases in Lesser Scaup (Aythya affinis) rather than Greater Scaup (Aythya marila) numbers. To identify factors possibly related to the decline, we estimated demographic parameters for a local population of Lesser Scaup at Erickson, Manitoba, that was well studied before declines occurred and compared these estimates to historic rates. On average, nests were initiated later than in the past, and recent estimates of nesting success and duckling survival were lower than historical estimates. Breeding-season survival of adult females was estimated as 72.6%, with most (83%) mortality occurring during nesting. Current estimates of demographic rates at Erickson are too low to maintain a stable local population, and suppressed reproductive rates might be the proximate cause of the local population decline

    Harvest and Non-Harvest Mortality Relationships for Lesser Scaup Breeding in Southwestern Montana

    Get PDF
    Since the mid-to-late 1990s, lesser scaup (Aythya affinis) populations have remained more than 20% below the population goal set forth in the North American Waterfowl Management Plan.  Accordingly, considerable attention has been directed towards understanding what factors may be limiting their population, including the role of harvest.  Red Rock Lakes National Wildlife Refuge (RRL) in southwestern Montana is the site of a long-term study of lesser scaup ecology and demography.  Preliminary harvest estimates indicate that this population is harvested at rates similar to the continental population with juveniles experiencing an annual average harvest rate of 9.1% (95% CI = 7.7 - 10.7%) and adults an average annual harvest rate of 3.6% (95% CI = 2.2 - 6.1%).  Since 2005, ~1,300 female have been banded on the study site and an additional ~1,000 females have been nasal-marked.  In addition, ~1,400 resightings have been collected for nasal-marked hens on the study site and ~340 dead recoveries from our study population have been reported from Canada to Mexico.  With results obtained from multistrata models that utilize these multiple encounter types, I will present (1) estimates of harvest and natural mortality rates for female lesser scaup banded and nasal-marked at RRL from 2005-2016; (2) how non-harvest mortality varies in relation to harvest mortality over the same period; (3) an assessment of how these rates respond to changes in hunting regulations.  These results will be used to help inform lesser scaup harvest demography, a key structural uncertainty in current harvest models identified in the draft Scaup Conservation Action Plan

    Harvest and Non-Harvest Mortality Relationships for Lesser Scaup Breeding in Southwestern Montana

    Get PDF
    Since the mid-to-late 1990s, lesser scaup (Aythya affinis) populations have remained more than 20% below the population goal set forth in the North American Waterfowl Management Plan.  Accordingly, considerable attention has been directed towards understanding what factors may be limiting their population, including the role of harvest.  Red Rock Lakes National Wildlife Refuge (RRL) in southwestern Montana is the site of a long-term study of lesser scaup ecology and demography with data from which survival and harvest rates can be estimated using capture-mark-recapture statistical techniques.  The role of harvest in regulating duck population dynamics, including lesser scaup, is clouded with uncertainty.  Decades of research into the additive or compensatory nature of harvest mortality has yielded little consensus as to which of these hypotheses prevail in North American duck populations.  The most limiting factor to assessing these relationships stems from lacking estimates of population size during waterfowl hunting seasons.  We assessed the relationship between survival rates and harvest rates for lesser scaup females breeding at RRL for an 11 years, beginning in 2005.  Consistent with predictions of density dependence regulation of natural mortality rates during the non-breeding season, we found evidence suggesting adult female survival rates fluctuate in response to harvest regulations, an index of population size, and the total number of lesser scaup harvested in the Pacific and Central Flyways

    Looking for a needle in a haystack: inference about individual fitness components in a heterogeneous population

    Get PDF
    Studies of wild vertebrates have provided evidence of substantial differences in lifetime reproduction among individuals and the sequences of life history ‘states’ during life (breeding, nonbreeding, etc.). Such differences may reflect ‘fixed’ differences in fitness components among individuals determined before, or at the onset of reproductive life. Many retrospective life history studies have translated this idea by assuming a ‘latent’ unobserved heterogeneity resulting in a fixed hierarchy among individuals in fitness components. Alternatively, fixed differences among individuals are not necessarily needed to account for observed levels of individual heterogeneity in life histories. Individuals with identical fitness traits may stochastically experience different outcomes for breeding and survival through life that lead to a diversity of ‘state’ sequences with some individuals living longer and being more productive than others, by chance alone. The question is whether individuals differ in their underlying fitness components in ways that cannot be explained by observable ‘states’ such as age, previous breeding success, etc. Here, we compare statistical models that represent these opposing hypotheses, and mixtures of them, using data from kittiwakes. We constructed models that accounted for observed covariates, individual random effects (unobserved heterogeneity), first-order Markovian transitions between observed states, or combinations of these features. We show that individual sequences of states are better accounted for by models incorporating unobserved heterogeneity than by models including first-order Markov processes alone, or a combination of both. If we had not considered individual heterogeneity, models including Markovian transitions would have been the best performing ones. We also show that inference about age-related changes in fitness components is sensitive to incorporation of underlying individual heterogeneity in models. Our approach provides insight into the sources of individual heterogeneity in life histories, and can be applied to other data sets to examine the ubiquity of our results across the tree of life

    The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Get PDF
    Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

    Lesser Scaup Population Dynamics: What Can Be Learned from Available Data?

    No full text
    Populations of Lesser Scaup (Aythya affinis) have declined markedly in North America since the early 1980s. When considering alternatives for achieving population recovery, it would be useful to understand how the rate of population growth is functionally related to the underlying vital rates and which vital rates affect population growth rate the most if changed (which need not be those that influenced historical population declines). To establish a more quantitative basis for learning about life history and population dynamics of Lesser Scaup, we summarized published and unpublished estimates of vital rates recorded between 1934 and 2005, and developed matrix life-cycle models with these data for females breeding in the boreal forest, prairie-parklands, and both regions combined. We then used perturbation analysis to evaluate the effect of changes in a variety of vital-rate statistics on finite population growth rate and abundance. Similar to Greater Scaup (Aythya marila), our modeled population growth rate for Lesser Scaup was most sensitive to unit and proportional change in adult female survival during the breeding and non-breeding seasons, but much less so to changes in fecundity parameters. Interestingly, population growth rate was also highly sensitive to unit and proportional changes in the mean of nesting success, duckling survival, and juvenile survival. Given the small samples of data for key aspects of the Lesser Scaup life cycle, we recommend additional research on vital rates that demonstrate a strong effect on population growth and size (e.g., adult survival probabilities). Our life-cycle models should be tested and regularly updated in the future to simultaneously guide science and management of Lesser Scaup populations in an adaptive context

    Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

    No full text
    International audienceIn this article, the name of the GLORIA-AF investigator Anastasios Kollias was given incorrectly as Athanasios Kollias in the Acknowledgements. The original article has been corrected

    Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry

    Get PDF
    Background: Previous studies suggested potential ethnic differences in the management and outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription, discontinuation, and risk of adverse outcomes in Asian patients with AF, using data from a global prospective cohort study. Methods: From the GLORIA-AF Registry Phase II-III (November 2011-December 2014 for Phase II, and January 2014-December 2016 for Phase III), we analysed patients according to their self-reported ethnicity (Asian vs. non-Asian), as well as according to Asian subgroups (Chinese, Japanese, Korean and other Asian). Logistic regression was used to analyse OAC prescription, while the risk of OAC discontinuation and adverse outcomes were analysed through Cox-regression model. Our primary outcome was the composite of all-cause death and major adverse cardiovascular events (MACE). The original studies were registered with ClinicalTrials.gov, NCT01468701, NCT01671007, and NCT01937377. Findings: 34,421 patients were included (70.0 ± 10.5 years, 45.1% females, 6900 (20.0%) Asian: 3829 (55.5%) Chinese, 814 (11.8%) Japanese, 1964 (28.5%) Korean and 293 (4.2%) other Asian). Most of the Asian patients were recruited in Asia (n = 6701, 97.1%), while non-Asian patients were mainly recruited in Europe (n = 15,449, 56.1%) and North America (n = 8378, 30.4%). Compared to non-Asian individuals, prescription of OAC and non-vitamin K antagonist oral anticoagulant (NOAC) was lower in Asian patients (Odds Ratio [OR] and 95% Confidence Intervals (CI): 0.23 [0.22-0.25] and 0.66 [0.61-0.71], respectively), but higher in the Japanese subgroup. Asian ethnicity was also associated with higher risk of OAC discontinuation (Hazard Ratio [HR] and [95% CI]: 1.79 [1.67-1.92]), and lower risk of the primary composite outcome (HR [95% CI]: 0.86 [0.76-0.96]). Among the exploratory secondary outcomes, Asian ethnicity was associated with higher risks of thromboembolism and intracranial haemorrhage, and lower risk of major bleeding. Interpretation: Our results showed that Asian patients with AF showed suboptimal thromboembolic risk management and a specific risk profile of adverse outcomes; these differences may also reflect differences in country-specific factors. Ensuring integrated and appropriate treatment of these patients is crucial to improve their prognosis. Funding: The GLORIA-AF Registry was funded by Boehringer Ingelheim GmbH

    The Changing Landscape for Stroke\ua0Prevention in AF

    No full text

    The Changing Landscape for Stroke Prevention in AF

    No full text
    corecore